IL2 and systemic lupus erythematosus: Consistent with these findings, LD-IL-2 has been shown to decrease the frequency of TFH cells, as defined by cell surface markers47, as well as the frequency of marginal zone B cells6 in SLE patients, supporting a role in the regulation of germinal centre reactions.